Pharmacogenomics is the study of how a person’s genes affect how they respond to medications. The field’s goal is to help doctors select the drugs and doses best suited for each person’s unique needs. Pharmacogenomics is interwoven with the field of precision medicine, which aims to treat each patient individually.
According to the Pharmacogenomics Market Report, the pharmacogenomics field is expected to experience a growth of 11% during the forecast period (2018–2026).
Future career opportunities are plentiful for students graduating with an MS in Pharmaceutical Sciences: Pharmacogenomics and Personalized Healthcare. Alumni can expect to be eligible for a variety of leadership roles and career-advancing opportunities.
As with other highly technical professions, a higher education level leads to increased opportunities, salary, and responsibility. Since this is a relatively new area, the process of entering the field can vary for different people, and a degree in a related subject such as genetics or pharmaceutics may be enough to start or excel in a career.
Pharmacogenomics is a sub-specialty of healthcare, used in several ways. From drug development to cancer therapy to food digestion, pharmacogenomics impacts any field involving human life.
The MS in Pharmacogenomics program is typically completed in 6 semesters or 2 years if taken part-time.
For the MS in Pharmacogenomics program, a grade-point average (GPA) of at least 3.00 or foreign equivalent is recommended.
Requirements include:
Please visit the Admissions Requirements page for more information.
Additional resources to support you from start to finish.
© 2024 University of Cincinnati Online Copyright Information